+86(1812)4514114 [email protected]

Tesamorelin (218949-48-5)

Enfuvirtide (also known as T-20) is a fusion inhibitor anti-AIDS targeted drug. Enfuvirtide is a 36 residue………

Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1512kg/month


Tesamorelin (218949-48-5) video


Tesamorelin (218949-48-5) Description

Tesamorelin is a stabilized synthetic peptide analogue of the hypothalamic peptide, Growth Hormone Releasing Hormone (GHRH) indicated for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a metabolic condition characterized by insulin resistance, fat redistribution, and hyperlipidemia associated with antiretroviral therapy for HIV infection.

Tesamorelin is used to reduce excess fat around the stomach that is caused by taking certain HIV medications. This condition is also called lipodystrophy (LYE-poe-DIS-troe-fee).

Tesamorelin (218949-48-5) Specifications

Product Name Tesamorelin
Chemical Name UNII-LGW5H38VE3; LGW5H38VE3; TH9507; Egrifta; Egrifta (TN)
Brand Name Egrifta
Drug Class Peptide
CAS Number 218949-48-5/804475-66-9
Molecular Formula C221H366N72O67S
Molecular Weight 5135.856 g/mol
Monoisotopic Mass 5135.86
Melting Point  N/A
Freezing Point N/A
Biological Half-Life 26 and 38 minutes in healthy subjects and HIV-infected patients, respectively.
Color White lyophilized powder
Solubility  Soluble in water and very slightly soluble in methanol.
Storage Temperature  -20°C Freezer
Application It can reduce excess fat (lipodystrophy) in the abdomen or stomach of HIV patients.




There are no reviews yet.

Be the first to review “Tesamorelin (218949-48-5)”

Your email address will not be published. Required fields are marked *

Shangke Chemical is a high-tech enterprise specializing in active pharmaceutical intermediates (APIs). To control the quality during production, a large number of experienced professionals, a first-class production equipment and laboratories are the key points.

Contact Us